Quick score of hormone receptor status of breast carcinoma: Correlation with the other clinicopathological prognostic parameters

Indian Journal of Pathology and Microbiology

Volumn 52, Issue 2, 2009, Pages 159-163

  Mudduwa, Lakmini K B ^a  

^a UNIVERSITY OF RUHUNA   (Sri Lanka)

Author keywords

Breast carcinoma; Hormone receptor status; Quick score

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DESCRIPTIVE RESEARCH; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOLOGY; PREVALENCE; PROGNOSIS; PROTEIN EXPRESSION; QUICK SCORE; RISK ASSESSMENT; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN; STATISTICS AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 63449133157     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.48906     Document Type: Article

References (12)

1. Yamashita H, Ando Y, Nishio M, Zhang Z, Hamaguchi M, Mita K, et al. Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer. Breast Cancer 2006;13:74-83.
2. Leake R, Barnes D, Pinder S, Ellis I, Anderson L, Anderson T, et al. Immunohistochemical detection of steroid receptors in breast cancer: A working protocol. J Clin Pathol 2000;53:634-5.
3. Guidelines Working Group of the National Coordinating Committee for Breast Pathology. Pathology reporting of breast diseases. NHSBSP Publication No. 58 January 2005. p. 86-7.
4. Ellis IO, Bartlett J, Dowsett M, Humphreys S, Jasani B, Miller K, et al. Best Practice No. 176: Updated recommendation for HER2 testing in the UK. J Clin Pathol 2004;57:322-7.
5. Elston CW, Ellis IO. Assessment of histological grade. In: Elston CW, Ellis IO, editors. The Breast. Great Britain: Redwood Books Ltd; 2000. p. 365-484.
6. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, et al. Revision of the American Joint Committee on Cancer Staging for breast cancer. J Clin Oncol 2002;20:3628-36.
7. Li CI, Darling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 2003;21:28-34.
8. Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF. Hormone receptor status of breast cancer in India: A study of 798 tumours. Breast 2000;9:267-70.
9. Sughayer MH, Al-Khawaja M, Massarweh S, Al-Masri M. Prevalence of hormone receptors and HER2/neu in breast cancer cases in Jordan. Pathol Oncol Res 2006;12:83-6.
10. Jirstrom K, Ryden L, Anagnostaki L. Nordenskjold B, Stal O, Thorstension S, et al. Pathology parameters and adjuvant tamoxifen response in a randomized premenopausal breast cancer trial. J Clin Pathol 2005;58:1135-42.
11. Wells CA, Sloane JP, Coleman D, Munt C, Amendoeira I, Apostolikas N, et al. Consistency of staining and reporting of oestrogen receptor immunohistochemistry within the Europian Union: An inter-laboratory study. Virchows Arch 2004;445:119-28.
12. Horii R, Akiyama F, Ito Y, Iwase T. Assessment of hormone receptor status in breast cancer. Pathol Int 2007;57:784-90.